JP4700808B2 - フルボ酸、および種々の状態の処置におけるその使用 - Google Patents

フルボ酸、および種々の状態の処置におけるその使用 Download PDF

Info

Publication number
JP4700808B2
JP4700808B2 JP2000573359A JP2000573359A JP4700808B2 JP 4700808 B2 JP4700808 B2 JP 4700808B2 JP 2000573359 A JP2000573359 A JP 2000573359A JP 2000573359 A JP2000573359 A JP 2000573359A JP 4700808 B2 JP4700808 B2 JP 4700808B2
Authority
JP
Japan
Prior art keywords
acid
oxyfulvic
salt
treatment
fulvic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP2000573359A
Other languages
English (en)
Japanese (ja)
Other versions
JP2002526407A5 (enExample
JP2002526407A (ja
Inventor
デッカー，ヨハネス
メドレン，コンスタンス・エリザベス
Original Assignee
プフェインスミス・リミテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by プフェインスミス・リミテッド filed Critical プフェインスミス・リミテッド
Publication of JP2002526407A publication Critical patent/JP2002526407A/ja
Publication of JP2002526407A5 publication Critical patent/JP2002526407A5/ja
Application granted granted Critical
Publication of JP4700808B2 publication Critical patent/JP4700808B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
JP2000573359A 1998-10-08 1999-10-08 フルボ酸、および種々の状態の処置におけるその使用 Expired - Fee Related JP4700808B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
ZA989190 1998-10-08
ZA99/2848 1999-04-21
ZA98/9190 1999-04-21
ZA992848 1999-04-21
PCT/IB1999/001649 WO2000019999A1 (en) 1998-10-08 1999-10-08 Fulvic acid and its use in the treatment of various conditions

Publications (3)

Publication Number Publication Date
JP2002526407A JP2002526407A (ja) 2002-08-20
JP2002526407A5 JP2002526407A5 (enExample) 2006-11-30
JP4700808B2 true JP4700808B2 (ja) 2011-06-15

Family

ID=27144980

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000573359A Expired - Fee Related JP4700808B2 (ja) 1998-10-08 1999-10-08 フルボ酸、および種々の状態の処置におけるその使用

Country Status (7)

Country Link
US (1) US6569900B1 (enExample)
EP (4) EP1700599B1 (enExample)
JP (1) JP4700808B2 (enExample)
AT (4) ATE410158T1 (enExample)
AU (1) AU766198B2 (enExample)
DE (4) DE69939720D1 (enExample)
WO (1) WO2000019999A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2570565C (en) * 2004-06-23 2012-10-23 Bioz Agri Products Inc. Method for extracting fulvic acid molecules
RU2280458C1 (ru) * 2004-11-30 2006-07-27 Алевтина Ивановна Косолапова Противовоспалительная мазь
WO2006064449A1 (en) * 2004-12-15 2006-06-22 Van Der Westhuizen Cornelis Fl Detoxifying and immunity-booster composition
US20080160111A1 (en) * 2005-02-28 2008-07-03 Hiroko Isoda Type I Allergy Inhibitor and Methods of Inhibiting the Onset of Type I Allergy Using Fulvic Acid
JP2006232785A (ja) * 2005-02-28 2006-09-07 Univ Of Tsukuba フルボ酸を用いるｉ型アレルギー抑制剤及びｉ型アレルギーの発症抑制方法。
US20070212434A1 (en) * 2006-03-07 2007-09-13 Day Kenneth S Compositions and methods for human use containing fulvic acid
BRPI0709711A2 (pt) 2006-05-02 2011-07-26 Pfeinsmith S A Pty Ltd composiÇço, e, mÉtodo de fabricar a mesma.
CN102099027B (zh) 2008-06-05 2012-12-12 皮费恩史密斯有限公司 富里酸及抗生素组合物
DE102008058552A1 (de) 2008-11-21 2010-05-27 Mankau, Dieter, Prof. Dr. Federrahmen und Federkörper zur Abstützung z. B. einer Matratze
GB0900786D0 (en) 2009-01-19 2009-03-04 Natracine Uk Ltd Therapeutic compositions
GB0914966D0 (en) * 2009-08-27 2009-09-30 Natracine Uk Ltd Fulvic acid compositions and their use
WO2013023062A1 (en) * 2011-08-09 2013-02-14 Wilford Lynn C Antimicrobial agents and methods for use thereof in the abatement of food borne pathogenic organisms
US9265744B2 (en) * 2012-03-07 2016-02-23 Natracine Uk Limited Fulvic acid and antibiotic combination for the inhibition or treatment of multi-drug resistant bacteria
CN105246879A (zh) 2013-05-28 2016-01-13 英派尔科技开发有限公司 腐植酸衍生物以及制备的方法和用途
EP3004070B1 (en) 2013-05-28 2017-10-11 Empire Technology Development LLC Antioxidant humic acid derivatives and methods of preparation and use
WO2014209369A1 (en) 2013-06-28 2014-12-31 Empire Technology Development Llc Edible plasticizers for food and food packaging films
WO2017102565A1 (en) * 2015-12-15 2017-06-22 Rita Dobmeyer Pharmaceutical composition comprising a fulvic acid and at least one boron-containing compound
US9820953B2 (en) * 2016-02-26 2017-11-21 Omni Bioceutical Innovations, Inc. Compositions of bioactive fulvate fractions and uses thereof
JP6120342B1 (ja) * 2016-03-08 2017-04-26 株式会社スタイルアンドバリュージャパン 美容組成物
CN113924084A (zh) * 2019-03-20 2022-01-11 瑞塔·多布迈尔 药物组合物
EP3799854A1 (en) 2019-10-01 2021-04-07 Stefan Johannes Fellner Extract of organic humified materials
WO2021226627A1 (en) * 2020-05-05 2021-11-11 Figene, Llc Reduction of cytokine storm and pathological inflammation including caused by coronavirus using sphagnum and extracts thereof
KR102258006B1 (ko) * 2020-12-22 2021-05-28 허교 풀빅산을 유효성분으로 포함하는 항바이러스 조성물
CN117064913A (zh) * 2023-02-23 2023-11-17 单士军 用于缓解特应性皮炎的黄腐酸外用制剂

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB244215A (en) 1924-10-09 1925-12-17 Richard William Bailey Improvements in or relating to gas or oil power plant
DE2850685A1 (de) * 1978-11-22 1980-06-04 Kneer Franz X Verfahren zur herstellung eines kolloiden schlammbades und schlammartiger pasten fuer die heilbehandlung
US5204368A (en) * 1990-05-25 1993-04-20 National Energy Council Bacteriostatic and bacteriocidal method using fulvic acid derivatives
JPH0466508A (ja) * 1990-07-03 1992-03-02 Suntory Ltd 抗菌剤
JPH0687752A (ja) * 1992-09-04 1994-03-29 Kyowa Kagaku Kogyo Kk 抗菌水及びこの抗菌水の製造方法
CN1097990A (zh) * 1994-01-29 1995-02-01 康宏盛 一种治疗股癣的药物
JPH1017483A (ja) * 1996-06-26 1998-01-20 Keinzu Corp:Kk 皮膚疾患予防及び治療剤
AP9801415A0 (en) * 1996-06-27 1998-12-31 Organoflo Pty Ltd A method of making a liquid fertilizing substance.
JPH119674A (ja) * 1997-06-25 1999-01-19 M S K Planning:Kk フミン酸を有効成分とする液体消臭剤と、その製造方法及びフミン酸を有効成分とした飲料用消臭剤と、その製造方法
CN1103339C (zh) * 1998-08-25 2003-03-19 祝亚勤 药用级泥炭黄腐植酸钠的制备方法

Also Published As

Publication number Publication date
AU766198B2 (en) 2003-10-09
ATE410158T1 (de) 2008-10-15
ATE410159T1 (de) 2008-10-15
EP1700599A1 (en) 2006-09-13
EP1700600A1 (en) 2006-09-13
DE69939720D1 (de) 2008-11-20
DE69932939D1 (de) 2006-10-05
US6569900B1 (en) 2003-05-27
DE69939721D1 (de) 2008-11-20
AU5992399A (en) 2000-04-26
ATE410160T1 (de) 2008-10-15
EP1698333A1 (en) 2006-09-06
ATE336997T1 (de) 2006-09-15
DE69932939T2 (de) 2006-12-07
DE69939722D1 (de) 2008-11-20
WO2000019999A1 (en) 2000-04-13
EP1700600B1 (en) 2008-10-08
EP1126837B1 (en) 2006-08-23
EP1700599B1 (en) 2008-10-08
EP1126837A1 (en) 2001-08-29
EP1698333B1 (en) 2008-10-08
JP2002526407A (ja) 2002-08-20

Similar Documents

Publication Publication Date Title
JP4700808B2 (ja) フルボ酸、および種々の状態の処置におけるその使用
US6709681B2 (en) Acidified nitrite as an antimicrobial agent
CA1050548A (en) Zinc sulfadiazine as a medicament
BG64522B1 (bg) Средство за лечение на вирусни инфекциозни заболявания
AU758264B2 (en) Inorganic nitrite and organic acid in combination as topical antiviral composition
JPH08502976A (ja) カルシウムおよび硫酸塩を含有した組成物および複合体、その合成法、これを用いた治療法、これを含んでなる化粧用調製物
Sande et al. In vivo antagonism between gentamicin and chloramphenicol in neutropenic mice
RU2504396C1 (ru) Фармацевтическая композиция, содержащая ферменты: коллагеназу и лизоцим и/или сангвиритрин
Harris et al. The development and evaluation of melatonin-loaded, calcium oxide nanoparticle-based neem and clove extract: an in vitro study
JPH03255033A (ja) 白癬治療剤
US11298393B2 (en) Composition comprising a mixture of an extract and bentonite
US20190117559A1 (en) Method of treating inflammation and promoting wound healing
RU2110272C1 (ru) Средство для лечения термических поражений кожи, трофических язв, пролежней и длительно незаживающих ран
CN108079050A (zh) 本草皮肤抑菌组合物及其制备方法与应用
RU2123348C1 (ru) Противолучевое средство
FR2566665A1 (fr) Composition pour inhiber le developpement des tumeurs, a base d'un derive d'acide peroxydiphosphorique
JP3058659B2 (ja) 生物的に利用可能な形態のミネラル
ZA200102419B (en) Fulvic acid and its use in the treatment of various conditions.
Ahmed et al. The effect of salvia officinalis aqueous extract on generation number and time of leishmania tropica
JPS6229530A (ja) ウナギの鰓病薬
WO2021180896A1 (en) Topical preparations
WO2016015691A1 (en) A pharmaceutical composition having antibacterial and virucidal effects
RU2486915C1 (ru) Фармацевтическая композиция, содержащая фермент дезоксирибонуклеазу и глицирризиновую кислоту или ее соли: глицирризинат аммония, или дикалия, или тринатрия
EA041405B1 (ru) Фармацевтическое средство для лечения артрологических заболеваний
JPH02262504A (ja) メラニン色素生成抑制剤

Legal Events

Date Code Title Description
A711 Notification of change in applicant

Free format text: JAPANESE INTERMEDIATE CODE: A711

Effective date: 20051206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20051206

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20061005

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20061005

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20100329

A601 Written request for extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A601

Effective date: 20100625

A602 Written permission of extension of time

Free format text: JAPANESE INTERMEDIATE CODE: A602

Effective date: 20100702

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20100729

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A821

Effective date: 20100730

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20100818

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20101220

A911 Transfer to examiner for re-examination before appeal (zenchi)

Free format text: JAPANESE INTERMEDIATE CODE: A911

Effective date: 20110119

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20110207

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20110307

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees